SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-01-501795
Filing Date
2001-08-14
Accepted
2001-08-14 00:00:00
Documents
9
Period of Report
2001-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q j1207_10q.htm 10-Q 128120
3 EX-10.33 j1207_ex10d33.htm EX-10.33 36027
4 EX-10.34 j1207_ex10d34.htm EX-10.34 37535
5 EX-10.35 j1207_ex10d35.htm EX-10.35 139660
6 EX-10.36 j1207_ex10d36.htm EX-10.36 141332
7 EX-10.37 j1207_ex10d37.htm EX-10.37 30469
8 EX-10.38 j1207_ex10d38.htm EX-10.38 60545
9 EX-10.39 j1207_ex10d39.htm EX-10.39 139331
10 EX-10.40 j1207_ex10d40.htm EX-10.40 92782
  Complete submission text file 0001104659-01-501795.txt   808264
Mailing Address ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258
Business Address ONE SW COLUMBIA STE 1105 PORTLAND OR 97258 5032270554
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 1710024
SIC: 2834 Pharmaceutical Preparations